UBS hebt Astrazeneca auf Neutral - Ziel 11300 Pence
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Aktien von Astrazeneca nach ihrem Kursrutsch bei unverändertem Kursziel von…
63,250€
-0,39%
Echtzeit-Aktienkurs ASTRAZENECA DL-,25 SP.ADR
Bid:
Ask:
Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie
International business development expert joins Dicot Pharma
Uppsala, Sweden, November 19, 2024. The potency drug developer Dicot Pharma, which recently initiated a phase 2a clinical trial and…
Tagrisso recommended for EU approval - LAURA
18 November 2024
Tagrisso recommended for approval in the EU by CHMP
for patients with unresectable EGFR-mutated lung cancer
Recommendation based on LAURA Phase III…
FIVE at FIVE: GSK, AstraZeneca plummet; LandSec profits; Economy stalls; FTSE 100 meanders; TT snubs Volex
1. Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK President-elect Donald Trump announced the controversial appointment of Robert…
Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK
Almost £7 billion was wiped from the combined market values of GSK PLC and AstraZeneca PLC on Friday after Donald Trump unveiled his…